Durable Mechanical Circulatory Support Devices

Progress in Cardiovascular Diseases

Volumn 54, Issue 2, 2011, Pages 132-143

  Patel, Chetan B ^a   Rogers, Joseph G ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Advanced heart failure; Bridge to transplant; Cardial transplantation; Destination therapy; Mechanical circulatory support; Ventricular assist devices

Indexed keywords

CLENBUTEROL; INOTROPIC AGENT;

AORTA VALVE REGURGITATION; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR RISK; CLINICAL TRIAL; DEFIBRILLATOR; DEVICE INFECTION; DISEASE CLASSIFICATION; HEART LEFT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MORTALITY; MULTICENTER STUDY (TOPIC); NONISCHEMIC CARDIOMYOPATHY; OVERALL SURVIVAL; PALLIATIVE THERAPY; PATIENT SELECTION; POSTOPERATIVE HEMORRHAGE; QUALITY OF LIFE; SYSTOLIC HEART FAILURE; TERMINAL CARE; THROMBOEMBOLISM;

DISEASE PROGRESSION; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; PATIENT SELECTION; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 80052140884     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2011.06.002     Document Type: Article

References (80)

1. Hershberger R.E., Nauman D., Walker T.L., et al. Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. J Card Fail 2003, 9:180-187.
2. Rogers J.G., Butler J., Lansman S.L., et al. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol 2007, 50:741-747.
3. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001, 345:1435-1443.
4. Jessup M., Brozena S. Heart failure. N Engl J Med 2003, 348:2007-2018.
5. Fang J.C. Rise of the machines-left ventricular assist devices as permanent therapy for advanced heart failure. N Engl J Med 2009, 361:2282-2285.
6. Taylor D.O., Stehlik J., Edwards L.B., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official Adult Heart Transplant Report-2009. J Heart Lung Transplant 2009, 28:1007-1022.
7. Frazier O.H., Delgado R.M. Mechanical circulatory support for advanced heart failure: where does it stand in 2003?. Circulation 2003, 108:3064-3068.
8. Felker G.M., Rogers J.G. Same bridge, new destinations rethinking paradigms for mechanical cardiac support in heart failure. J Am Coll Cardiol 2006, 47:930-932.
9. Baughman K.L., Jarcho J.A. Bridge to life-cardiac mechanical support. N Engl J Med 2007, 357:846-849.
10. Stevenson L.W., Rose E.A. Left ventricular assist devices: bridges to transplantation, recovery, and destination for whom?. Circulation 2003, 108:3059-3063.
11. Sandner S.E., Wieselthaler G., Zuckermann A., et al. Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation. Circulation 2001, 104:I171-I176.
12. Lietz K., Miller L.W. Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/U.S. United Network of Organ Sharing data, 1990 to 2005. J Am Coll Cardiol 2007, 50:1282-1290.
13. Johnson MR, Meyer KH, Haft J, et al: Heart transplantation in the United States, 1999-2008. Am J Transplant;10:1035-1046.
14. Frazier O.H., Rose E.A., Oz M.C., et al. Multicenter clinical evaluation of the heartmate; vented electric left ventricular assist system in patients awaiting heart transplantation. J Heart Lung Transplant 2001, 20:201-202.
15. Deng M.C., Edwards L.B., Hertz M.I., et al. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report-2005. J Heart Lung Transplant 2005, 24:1182-1187.
16. Miller L.W., Pagani F.D., Russell S.D., et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007, 357:885-896.
17. Goldstein D.J. Worldwide experience with the MicroMed DeBakey Ventricular Assist Device as a bridge to transplantation. Circulation 2003, 108(Suppl 1):II272-II277.
18. Kirklin J.K., Naftel D.C., Stevenson L.W., et al. INTERMACS database for durable devices for circulatory support: first annual report. J Heart Lung Transplant 2008, 27:1065-1072.
19. Holman W.L., Kormos R.L., Naftel D.C., et al. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. J Heart Lung Transplant 2009, 28:44-50.
20. Larose JA, Tamez D, Ashenuga M, et al: Design concepts and principle of operation of the HeartWare ventricular assist system. ASAIO J.
21. Tuzun E., Roberts K., Cohn W.E., et al. In vivo evaluation of the HeartWare centrifugal ventricular assist device. Tex Heart Inst J 2007, 34:406-411.
22. Boyle A.U.S. Experience with a novel centrifugal LVAD in bridge to transplant patients. J Heart Lung Transplant 2009, 80-81.
23. Aaronson K.D. Evaluation of the HeartWare HVAD left ventricular assist device system for the treatment of advanced heart failure: results of the ADVANCE bridge to transplant trial. Circulation 2010, 122:2215-2226.
24. Morshuis M, El-Banayosy A, Arusoglu L, et al. European experience of DuraHeart magnetically levitated centrifugal left ventricular assist system. Eur J Cardiothorac Surg 2009, 35:1020-1027. [discussion 7-8].
25. Frazier O.H., Rose E.A., Macmanus Q., et al. Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg 1992, 53:1080-1090.
26. Lietz K., Miller L.W. Patient selection for left-ventricular assist devices. Curr Opin Cardiol 2009, 24:246-251.
27. Mancini D, Lietz K. Selection of cardiac transplantation candidates in 2010;Circulation 122:173-183.
28. Hernandez A.F., Grab J.D., Gammie J.S., et al. A decade of short-term outcomes in post cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons' National Cardiac Database. Circulation 2007, 116:606-612.
29. Hernandez A.F., Shea A.M., Milano C.A., et al. Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. JAMA 2008, 300:2398-2406.
30. John R, Pagani FD, Naka Y, et al. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: Impact of duration of left ventricular assist device support and other variables. J Thorac Cardiovasc Surg.
31. Pal JD, Piacentino V, Cuevas AD, et al. Impact of left ventricular assist device bridging on posttransplant outcomes. Ann Thorac Surg 2009, 88:1457-1461. [discussion 61].
32. Rogers JG, Aaronson KD, Boyle AJ, et al: Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol 55:1826-1834.
33. Hunt S.A., Abraham W.T., Chin M.H., et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009, 119:e391-e479.
34. Thomas S., Rich M.W. Epidemiology, pathophysiology, and prognosis of heart failure in the elderly. Heart Fail Clin 2007, 3:381-387.
35. Russo M.J., Gelijns A.C., Stevenson L.W., et al. The cost of medical management in advanced heart failure during the final two years of life. J Card Fail 2008, 14:651-658.
36. Slaughter M.S., Rogers J.G., Milano C.A., et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009, 361:2241-2251.
37. Russell S.D., Rogers J.G., Milano C.A., et al. Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation 2009, 120:2352-2357.
38. Radovancevic B., Vrtovec B., de Kort E., et al. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices. J Heart Lung Transpl 2007, 26:815-818.
39. Lindenfeld J., Feldman A.M., Saxon L., et al. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Circulation 2007, 115:204-212.
40. Baldwin JT, Mann DL. NHLBI's program for VAD therapy for moderately advanced heart failure: the REVIVE-IT pilot trial. J Card Fail 16:855-858.
41. Daneshmand MA, Rajagopal K, Lima B, et al. Left ventricular assist device destination therapy versus extended criteria cardiac transplant. Ann Thorac Surg;89:1205-1209; [discussion 10].
42. Aaronson K.D., Schwartz J.S., Chen T.M., et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997, 95:2660-2667.
43. Levy W.C., Mozaffarian D., Linker D.T., et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 2006, 113:1424-1433.
44. Levy W.C., Mozaffarian D., Linker D.T., et al. Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy?. J Heart Lung Transplant 2009, 28:231-236.
45. Gorodeski EZ, Chu EC, Chow CH, et al: Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee. Circ Heart Fail 3:706-714.
46. Alba A.C., Rao V., Ivanov J., et al. Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation. J Heart Lung Transplant 2009, 28:827-833.
47. Kirklin JK, Naftel DC, Kormos RL, et al: Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant;29:1-10.
48. Kormos RL, Teuteberg JJ, Pagani FD, et al: Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 139:1316-1324.
49. Lee S, Kamdar F, Madlon-Kay R, et al: Effects of the HeartMate II continuous-flow left ventricular assist device on right ventricular function. J Heart Lung Transplant 29:209-215.
50. Matthews J.C., Koelling T.M., Pagani F.D., et al. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 2008, 51:2163-2172.
51. Ochiai Y., McCarthy P.M., Smedira N.G., et al. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation 2002, 106:I198-I202.
52. Slaughter MS, Pagani FD, Rogers JG, et al: Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 29:S1-S39.
53. Boyle A.J., Russell S.D., Teuteberg J.J., et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant 2009, 28:881-887.
54. John R, Kamdar F, Liao K, et al: Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg 2008;86:1227-1234; [discussion 34-5].
55. Pagani F.D., Miller L.W., Russell S.D., et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 2009, 54:312-321.
56. Crow S., John R., Boyle A., et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg 2009, 137:208-215.
57. Stern DR, Kazam J, Edwards P, et al: Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD. J Card Surg;25:352-6.
58. Seow C.H., Zimmerman M.J. Capsule endoscopy in the detection of small-intestinal bleeding in patients supported by a nonpulsatile axial-flow Jarvik 2000 left ventricular assist device. Gastrointest Endosc 2006, 63:1087.
59. Letsou G.V., Shah N., Gregoric I.D., et al. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant 2005, 24:105-109.
60. Geisen U., Heilmann C., Beyersdorf F., et al. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg 2008, 33:679-684.
61. Uriel N, Pak SW, Jorde UP, et al: Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol;56:1207-1213.
62. Crow S, Chen D, Milano C, et al: Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg;90:1263-1269; [discussion 9].
63. Meyer AL, Malehsa D, Bara C, et al: Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail;3:675-681.
64. Kimball P.M., Flattery M., McDougan F., et al. Cellular immunity impaired among patients on left ventricular assist device for 6 months. Ann Thorac Surg 2008, 85:1656-1661.
65. Cowger J, Pagani FD, Haft JW, et al: The development of aortic insufficiency in left ventricular assist device-supported patients. Circ Heart Fail;3:668-674.
66. Pak SW, Uriel N, Takayama H, et al: Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. J Heart Lung Transplant;29:1172-1176.
67. Mudd J.O., Cuda J.D., Halushka M., et al. Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device. J Heart Lung Transplant 2008, 27:1269-1274.
68. Velez M., Johnson M.R. Management of allosensitized cardiac transplant candidates. Transplant Rev (Orlando) 2009, 23:235-247.
69. Drakos S.G., Kfoury A.G., Kotter J.R., et al. Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization. J Heart Lung Transplant 2009, 28:838-842.
70. Drakos S.G., Stringham J.C., Long J.W., et al. Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions. J Thorac Cardiovasc Surg 2007, 133:1612-1619.
71. Stringham J.C., Bull D.A., Fuller T.C., et al. Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization. J Heart Lung Transplant 1999, 18:160-165.
72. Pamboukian S.V., Costanzo M.R., Dunlap S., et al. Relationship between bridging with ventricular assist device on rejection after heart transplantation. J Heart Lung Transplant 2005, 24:310-315.
73. Garatti A, Bruschi G, Colombo T, et al: Clinical outcome and bridge to transplant rate of left ventricular assist device recipient patients: comparison between continuous-flow and pulsatile-flow devices. Eur J Cardiothorac Surg 2008;34:275-280; [discussion 80].
74. Klotz S., Wenzelburger F., Stypmann J., et al. Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant. Ann Thorac Surg 2006, 82:1770-1773.
75. Alba AC, Rao V, Ross HJ, et al: Impact of fixed pulmonary hypertension on post-heart transplant outcomes in bridge-to-transplant patients. J Heart Lung Transplant;29:1253-1258.
76. Oswald H, Schultz-Wildelau C, Gardiwal A, et al: Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients. Eur J Heart Fail;12:593-599.
77. Andersen M., Videbaek R., Boesgaard S., et al. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transplant 2009, 28:733-735.
78. Mancini D.M., Beniaminovitz A., Levin H., et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 1998, 98:2383-2389.
79. Birks E.J., Tansley P.D., Hardy J., et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006, 355:1873-1884.
80. Brush S, Budge D, Alharethi R, et al: End-of-life decision making and implementation in recipients of a destination left ventricular assist device. J Heart Lung Transplant;29:1337-1341.